These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23749934)

  • 1. Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice.
    Pistelli M; Pagliacci A; Battelli N; Santinelli A; Biscotti T; Ballatore Z; Berardi R; Cascinu S
    Anticancer Res; 2013 Jun; 33(6):2737-42. PubMed ID: 23749934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
    Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
    Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.
    Li J; Liu X; Tong Z
    Jpn J Clin Oncol; 2012 Jun; 42(6):471-6. PubMed ID: 22493058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy.
    Asaga S; Kinoshita T; Hojo T; Suzuki J; Jimbo K; Tsuda H
    Clin Breast Cancer; 2013 Feb; 13(1):40-6. PubMed ID: 23103363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
    Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
    Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
    Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].
    Yuan ZY; Wang SS; Gao Y; Su ZY; Luo WB; Guan ZZ
    Ai Zheng; 2008 Jun; 27(6):561-5. PubMed ID: 18570725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
    Partin JF; Mamounas EP
    Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
    Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
    Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.
    Sabatier R; Jacquemier J; Bertucci F; Esterni B; Finetti P; Azario F; Birnbaum D; Viens P; Gonçalves A; Extra JM
    Eur J Cancer; 2011 Jul; 47(10):1537-45. PubMed ID: 21392964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of triple negative phenotype in conservatively treated breast cancer.
    Barbieri V; Sanpaolo P; Genovesi D
    Breast J; 2011; 17(4):377-82. PubMed ID: 21615820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
    Lin C; Chien SY; Kuo SJ; Chen LS; Chen ST; Lai HW; Chang TW; Chen DR
    Jpn J Clin Oncol; 2012 Mar; 42(3):161-7. PubMed ID: 22287721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple negative breast cancer: adjuvant chemotherapy effect on survival.
    Steponaviciene L; Lachej-Mikeroviene N; Smailyte G; Aleknavicius E; Meskauskas R; Didziapetriene J
    Adv Med Sci; 2011; 56(2):285-90. PubMed ID: 22112429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?
    Pignol JP; Rakovitch E; Olivotto IA
    J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459
    [No Abstract]   [Full Text] [Related]  

  • 19. p53 as a specific prognostic factor in triple-negative breast cancer.
    Chae BJ; Bae JS; Lee A; Park WC; Seo YJ; Song BJ; Kim JS; Jung SS
    Jpn J Clin Oncol; 2009 Apr; 39(4):217-24. PubMed ID: 19304743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Triple-negative breast cancer--towards a new entity].
    Miron L; Marinca A; Marinca M; Miron I
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):51-8. PubMed ID: 18677903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.